The CathWorks FFRangio ® System to Be Featured in Multiple Scientific Presentations Including the First Ever Prospective RCT Comparing an Angio-based Physiology Tool Versus FFR in Japan NEWPORT BEACH, Calif. , Oct. 25, 2024 /PRNewswire/ -- CathWorks, a global leader in digital health innovations, announced today the schedule of key events for the company during the upcoming Cardiovascular Research Foundation's annual Transcatheter Cardiovascular Therapeutics (TCT) conference taking place October 27 to 30 at the Walter E.
Washington Convention Center in Washington, DC . The CathWorks FFRangio ® System will be featured in scientific presentations, an educational symposium, and will be available for hands-on demonstrations and peer-to-peer education during Meet the Expert sessions hosted by leading physicians. For the first time ever, the CathWorks booth will include its own media studio where key opinion leaders will be invited to share their candid thoughts on various hot topics in the physiology and cardiovascular space.
Scientific Presentations On Sunday, Professor Hitoshi Matsuo from Gifu Heart Center in Gifu, Japan will present data from the PROVISION 1 study, the first ever Japanese prospective randomized controlled trial (RCT) comparing clinical outcomes of an angio-based physiology technology versus wire-based FFR. Professor Hitoshi Matsuo stated, "This study can play a pivotal role in how patients with coronary artery disease are diagnosed and treated going forward. .
